Literature DB >> 21667335

The role of HIV replicative fitness in perinatal transmission of HIV.

Xue-Qing Chen1, Chang Liu, Xiao-Hong Kong.   

Abstract

Perinatal transmission of Human immunodeficiency virus (HIV), also called mother-to-child transmission (MTCT), accounts for 90% of infections in infants worldwide and occurs in 30%-45% of children born to untreated HIV-1 infected mothers. Among HIV-1 infected mothers, some viruses are transmitted from mothers to their infants while others are not. The relationship between virologic properties and the pathogenesis caused by HIV-1 remains unclear. Previous studies have demonstrated that one obvious source of selective pressure in the perinatal transmission of HIV-1 is maternal neutralizing antibodies. Recent studies have shown that viruses which are successfully transmitted to the child have growth advantages over those not transmitted, when those two viruses are grown together. Furthermore, the higher fitness is determined by the gp120 protein of the virus envelope. This suggests that the selective transmission of viruses with higher fitness occurred exclusively, regardless of transmission routes. There are many factors contributing to the selective transmission and HIV replicative fitness is an important one that should not be neglected. This review summarizes current knowledge of the role of HIV replicative fitness in HIV MTCT transmission and the determinants of viral fitness upon MTCT.

Entities:  

Mesh:

Year:  2011        PMID: 21667335      PMCID: PMC8222459          DOI: 10.1007/s12250-011-3180-2

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  60 in total

1.  Preventing vertical transmission of HIV in Kinshasa, Democratic Republic of the Congo: a baseline survey of 18 antenatal clinics.

Authors:  Frieda Mtf Behets; Richard Matendo; Lara Me Vaz; Nick Kilese; Diderot Nanlele; Jack Kokolomami; Emile W Okitolando; Annelies Van Rie
Journal:  Bull World Health Organ       Date:  2006-12       Impact factor: 9.408

2.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

3.  Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period.

Authors:  Lertlakana Bhoopat; Surapan Khunamornpong; Pannee Sirivatanapa; Tat Rithaporn; Piyaporn Lerdsrimongkol; Paul S Thorner; Tanin Bhoopat
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

4.  Gender differences in perinatal HIV acquisition among African infants.

Authors:  Taha E Taha; Samah Nour; Newton I Kumwenda; Robin L Broadhead; Susan A Fiscus; George Kafulafula; Chiwawa Nkhoma; Shu Chen; Donald R Hoover
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

5.  Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus.

Authors:  Katherine T Chen; Marta Segú; L H Lumey; Louise Kuhn; Rosalind J Carter; Marc Bulterys; Elaine J Abrams
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

6.  Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.

Authors:  Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

7.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

Authors:  A B van't Wout; N A Kootstra; G A Mulder-Kampinga; N Albrecht-van Lent; H J Scherpbier; J Veenstra; K Boer; R A Coutinho; F Miedema; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.

Authors:  R E Dickover; E M Garratty; S A Herman; M S Sim; S Plaeger; P J Boyer; M Keller; A Deveikis; E R Stiehm; Y J Bryson
Journal:  JAMA       Date:  1996-02-28       Impact factor: 56.272

10.  [Orphans in Brazzaville orphanages].

Authors:  A Mouko; A Mbika-Cardorelle; V Mboungou; J B Mambou; J R Ibara; P Senga
Journal:  Sante       Date:  2009 Jan-Mar
View more
  1 in total

1.  Clinical Determinants of HIV-1B Between-Host Evolution and their Association with Drug Resistance in Pediatric Patients.

Authors:  Israel Pagán; Patricia Rojas; José Tomás Ramos; África Holguín
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.